Colporrhaphy using elastic tissue continuous with and obscured behind the fibromuscular layer of the vaginal wall
- PMID: 36859653
- DOI: 10.1111/jog.15613
Colporrhaphy using elastic tissue continuous with and obscured behind the fibromuscular layer of the vaginal wall
Abstract
Aim: Due to the U.S. Food and Drug Administration's order to cease the use of surgical mesh for transvaginal repair, an improvement of the native tissue repair (NTR) of pelvic organ prolapse (POP) could become important as one of the first-line operative methods. This study details the surgical technique of an NTR method we developed, with report of our 5 years of experience.
Methods: Operative technique: A new fibromuscular layer (FL) was constructed using a thick and elastic tissue continuous with and obscured behind the original FL of the vaginal wall.
Patients: Between April 2017 and March 2020, we performed our novel repair technique on 87 women with POP of either quantification stage III or IV.
Results: We followed up 80 of the 87 women for over 24 months up to 60 months (follow-up rate: 91.2%). POP recurred (defined as stage II or higher) in four patients (5.0%). Operation time was 49-70 min. The bleeding volume was 70-250 g. There were no intra- or postoperative complications that required further treatment.
Conclusions: This procedure could potentially become one of the first-line operative methods for repairing POP.
Keywords: colporrhaphy; first-line operative method; native tissue repair; pelvic organ prolapse; recurrence.
© 2023 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.
References
REFERENCES
-
- Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501-6.
-
- Maher C, Feiner B, Baessler K, Schmid C, Haya N, Brown J. Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev. 2016;11(11):CD004014.
-
- U.S. Food and Drug Administration. FDA takes action to protect women's health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices. 2019. Available from: https://www.fda.gov/news-events/press-announcements/fda-takes-action-pro...
-
- Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175:10-7.
-
- Richardson AC, Edmonds PB, Williams NL. Treatment of stress urinary incontinence due to paravaginal fascial defect. Obstet Gynecol. 1981;57:357-62.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
